Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Clinical trial NCT05201404 · RECRUITING
Trial details
- NCT number
- NCT05201404
- Sponsor
- Can-Fite BioPharma
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2026-02-01
- Enrollment
- 471
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.